| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1367-5931(03)00081-4 |
| P698 | PubMed publication ID | 12941423 |
| P2093 | author name string | Stephen J Lippard | |
| Christiana Xin Zhang | |||
| P2860 | cites work | Therapeutic radiopharmaceuticals | Q28212219 |
| Design and therapeutic application of matrix metalloproteinase inhibitors | Q28212260 | ||
| Manganese(III) biliverdin IX dimethyl ester: a powerful catalytic scavenger of superoxide employing the Mn(III)/Mn(IV) redox couple | Q32064368 | ||
| Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease | Q33953052 | ||
| Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro | Q34047176 | ||
| Recognition of cisplatin adducts by cellular proteins | Q34282236 | ||
| Cisplatin: from DNA damage to cancer chemotherapy. | Q34348474 | ||
| Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals | Q34393336 | ||
| Transferrin/transferrin receptor-mediated drug delivery. | Q34587503 | ||
| Molecular aspects of resistance to antitumor platinum drugs. | Q34866688 | ||
| Metal complexing agents as therapies for Alzheimer's disease | Q35019437 | ||
| Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin | Q35747835 | ||
| A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts | Q36620632 | ||
| In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer | Q37352731 | ||
| p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells | Q37385633 | ||
| Different recognition of DNA modified by aatitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53. | Q38302471 | ||
| Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I). | Q40654861 | ||
| Testis-specific HMG-domain protein alters the responses of cells to cisplatin | Q40711026 | ||
| The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway | Q40715456 | ||
| Hypotensive properties and acute toxicity of trans-[Ru(NH(3))(4)P(OEt)(3)(NO)](PF(6))(3), a new nitric oxide donor | Q40732264 | ||
| Mechanistic studies on AMD6221: a ruthenium-based nitric oxide scavenger | Q40743483 | ||
| Inhibition of cancer cell growth by ruthenium(II) arene complexes | Q40774119 | ||
| High-throughput synthesis and screening of platinum drug candidates | Q40835835 | ||
| Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds | Q40853299 | ||
| Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes | Q41144493 | ||
| In vivo effects of the controlled NO donor/scavenger ruthenium cyclam complexes on blood pressure | Q42526193 | ||
| cis-Dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-carboxamides: synthesis and action in resistant cell lines in vitro. | Q43643253 | ||
| Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. | Q43653393 | ||
| Estrogen-derived steroidal metal complexes: agents for cellular delivery of metal centers to estrogen receptor-positive cells. | Q43683418 | ||
| Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system | Q43702217 | ||
| Design of macromolecular prodrug of cisplatin using dextran with branched galactose units as targeting moieties to hepatoma cells | Q43800374 | ||
| Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore | Q43812059 | ||
| Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance. | Q43821272 | ||
| Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells. | Q43922040 | ||
| Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties | Q43946320 | ||
| Binding to cisplatin-modified DNA by the Saccharomyces cerevisiae HMGB protein Nhp6A. | Q43968612 | ||
| Hematoporphyrin-derived soluble porphyrin-platinum conjugates with combined cytotoxic and phototoxic antitumor activity | Q43977115 | ||
| Soluble tetraarylporphyrin-platinum conjugates as cytotoxic and phototoxic antitumor agents | Q43977118 | ||
| The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells. | Q43984243 | ||
| Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)]. | Q44020716 | ||
| DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair | Q44133887 | ||
| Cytotoxic acridinylthiourea and its platinum conjugate produce enzyme-mediated DNA strand breaks | Q44148584 | ||
| The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae | Q44187748 | ||
| Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines. | Q44215847 | ||
| Electrostatic contribution in the catalysis of O2*- dismutation by superoxide dismutase mimics. MnIIITE-2-PyP5+ versus MnIIIBr8T-2-PyP+. | Q44244866 | ||
| Ruthenium(III) polyaminocarboxylate complexes: efficient and effective nitric oxide scavengers | Q44363334 | ||
| In vitro and in vivo antitumor properties of tetrakis((trishydroxy- methyl)phosphine)gold(I) chloride. | Q44368091 | ||
| Cholic acid-carboplatin compounds (CarboChAPt) as models for specific drug delivery: synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic properties with corresponding cisplatin compounds | Q44384840 | ||
| DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines | Q44446747 | ||
| Metal complexes as enzyme inhibitors | Q46308676 | ||
| Nucleotide excision repair from site-specifically platinum-modified nucleosomes. | Q51836720 | ||
| Structure, Recognition, and Processing of Cisplatin-DNA Adducts. | Q55035583 | ||
| Current status of trans-platinum compounds in cancer therapy | Q59172903 | ||
| Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464 | Q73752006 | ||
| Medicinal inorganic chemistry: introduction | Q77367161 | ||
| Metal complexes as photo- and radiosensitizers | Q77367176 | ||
| Treatment of Wilson and menkes diseases | Q77367188 | ||
| Functional mimics of superoxide dismutase enzymes as therapeutic agents | Q77367198 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 481-489 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Current Opinion in Chemical Biology | Q15758415 |
| P1476 | title | New metal complexes as potential therapeutics | |
| P478 | volume | 7 |
| Q37611695 | 1,10-Phenanthroline-5,6-Dione-Based Compounds Are Effective in Disturbing Crucial Physiological Events of Phialophora verrucosa. |
| Q35967907 | A Review of Clinical Translation of Inorganic Nanoparticles. |
| Q38956634 | A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex |
| Q39524936 | A comparative study of DNA binding and cell cycle phase perturbation by the dinuclear complex of Cd(II) with the condensation product of 2-acetylpyridine and malonic acid dihydrazide N',N'(2) -bis[(1E)-1-(2-pyridyl)ethylidene]propanedihydrazide |
| Q58921543 | A dinuclear cyclometalated gold(iii)–phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo |
| Q34169479 | A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling |
| Q39181502 | A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin |
| Q35868560 | A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence |
| Q39261012 | A tri-copper(II) complex displaying DNA-cleaving properties and antiproliferative activity against cancer cells |
| Q40673716 | Activity of fluconazole and its Cu(II) complex towards Candida species. |
| Q41680103 | Acute and subchronic toxicity of the antitumor agent rhodium (II) citrate in Balb/c mice after intraperitoneal administration. |
| Q40737623 | Albumin binding and ligand-exchange processes of the Ru(III) anticancer agent NAMI-A and its bis-DMSO analogue determined by ENDOR spectroscopy |
| Q30855124 | An unusual ligand coordination gives rise to a new family of rhodium metalloinsertors with improved selectivity and potency |
| Q59101621 | Anticancer Activities of Mononuclear Ruthenium(II) Coordination Complexes |
| Q59082814 | Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes |
| Q39541261 | Anticancer gold(I)-phosphine complexes as potent autophagy-inducing agents |
| Q36687247 | Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer |
| Q87732541 | Apoptotic effects of dipyrido [3,2-a:2',3'-c] phenazine (dppz) Au(III) complex against diethylnitrosamine/phenobarbital induced experimental hepatocarcinogenesis in rats |
| Q36560196 | Axial ligand exchange of N-heterocyclic cobalt(III) Schiff base complexes: molecular structure and NMR solution dynamics. |
| Q34509157 | BODIPY-phosphane as a versatile tool for easy access to new metal-based theranostics. |
| Q45858014 | Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure |
| Q58172250 | Biological activity of synthetic ionophores: ion transporters as prospective drugs? |
| Q39801632 | Biological effects of combined ultrasound and cisplatin treatment on ovarian carcinoma cells. |
| Q33199658 | Biophysical characterization and molecular modeling of the coordinative-intercalative DNA monoadduct of a platinum-acridinylthiourea agent in a site-specifically modified dodecamer |
| Q57528873 | Bis(o-methylserotonin)-containing iridium(III) and ruthenium(II) complexes as new cellular imaging dyes: synthesis, applications, and photophysical and computational studies |
| Q38623221 | Bovine Serum Albumin Interactions with Metal Complexes |
| Q36823229 | Catalytic organometallic anticancer complexes |
| Q38986073 | Catecholase activity, DNA cleavage and cytotoxicity of six Zn(II) complexes synthesized from designed Mannich ligands: higher reactivity of mononuclear over dinuclear. |
| Q39991099 | Cellular uptake and distribution of cobalt complexes of fluorescent ligands |
| Q50288394 | Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii |
| Q52553038 | Cisplatin and cisplatin analogues perfusion through isolated rat heart: the effects of acute application on oxidative stress biomarkers. |
| Q37855898 | Copper, gold and silver compounds as potential new anti-tumor metallodrugs |
| Q51001771 | Covalent binding and conformational change of pUC19 DNA by rhodium (II) metal complex. |
| Q46881282 | Cucurbit[n]uril binding of platinum anticancer complexes |
| Q57371914 | Cyclotriphosphazene-Pt-DACH Conjugates with Dipeptide Spacers for Drug Delivery Systems |
| Q59793490 | Cytotoxic phenanthroline derivatives alter metallostasis and redox homeostasis in neuroblastoma cells |
| Q27702884 | Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives |
| Q39402733 | Cytotoxicity and DNA interactions of some platinum(II) complexes with substituted benzimidazole ligands. |
| Q39689905 | Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines. |
| Q45811861 | DNA binding and oxidative DNA cleavage activity of (mu-oxo)diiron(iii) complexes in visible light. |
| Q31043552 | DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes. |
| Q57289654 | DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands |
| Q39668149 | DNA binding, cytotoxicity, and apoptotic-inducing activity of ruthenium(II) polypyridyl complex. |
| Q33835903 | DNA binding, prominent DNA cleavage and efficient anticancer activities of tris(diimine)iron(II) complexes |
| Q34042848 | DNA-Destabilizing Agents as an Alternative Approach for Targeting DNA: Mechanisms of Action and Cellular Consequences |
| Q92465999 | Design, Synthesis, and Targeted Delivery of Fluorescent 1,2,4-Triazole-Peptide Conjugates to Pediatric Brain Tumor Cells |
| Q38974558 | Designing metallodrugs with nuclease and protease activity. |
| Q37687110 | Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer |
| Q39695089 | Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator |
| Q57615028 | Dispersed Gold Nanoparticles Supported in the Pores of Siliceous Mesocellular Foam: A Catalyst for Cycloisomerization of Alkynoic Acids to γ-Alkylidene Lactones |
| Q38221279 | Enhancing vascular relaxing effects of nitric oxide-donor ruthenium complexes |
| Q53223436 | Evaluation of reproductive toxicity in male rats treated with novel synthesized ruthenium(II) and gold(I)-NHC complexes. |
| Q39746460 | Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study |
| Q40663635 | Exploring the copper(II)-aminotriazole complex-binding sites of human serum albumin |
| Q34778423 | Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy |
| Q52860466 | Genotoxicity of Casiopeina III-Ea in mouse bone marrow cells. |
| Q39166884 | Gold amides as anticancer drugs: synthesis and activity studies |
| Q33279394 | Gold(I)-isocyanide and gold(I)-carbene complexes as substrates for the laser decoration of gold onto ceramic surfaces |
| Q86191005 | Gold-phosphine-porphyrin as potential metal-based theranostics |
| Q55652601 | High-Technology Therapy Using Biomolecules or Synthetic Compounds for HIV Inhibition |
| Q38827449 | Highly Stable Tetra-Phenolato Titanium(IV) Agent Formulated into Nanoparticles Demonstrates Anti-Tumoral Activity and Selectivity |
| Q38968421 | Highly cytotoxic DNA-interacting copper(II) coordination compounds |
| Q38796884 | In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex |
| Q36662593 | In vitro evaluation of a stable monomeric gold(II) complex with hematoporphyrin IX: cytotoxicity against tumor and kidney cells, cellular accumulation, and induction of apoptosis. |
| Q39728594 | In vitro pharmacological study of monomeric platinum(III) hematoporphyrin IX complexes. |
| Q60212615 | Influence of the Diketonato Ligand on the Cytotoxicities of [Ru(η6-p-cymene)(R2acac)(PTA)]+ Complexes (PTA = 1,3,5-triaza-7-phosphaadamantane) |
| Q39028760 | Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies |
| Q27687736 | Interactions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compound |
| Q27695726 | Interactions of gold-based drugs with proteins: the structure and stability of the adduct formed in the reaction between lysozyme and the cytotoxic gold(III) compound Auoxo3 |
| Q50452519 | Interfacial properties and in vitro cytotoxic effects of surface-modified near infrared absorbing Au-Au(2)S nanoparticles |
| Q48218977 | Iridium Complexes as a Roadblock for DNA Polymerase during Amplification |
| Q58383629 | Iridium(III) Complexes of Terpyridine- and Terpyridine-Analogous Ligands Bearing Sugar Residues and Their in vitro Activity |
| Q36539791 | Light-Sensitive Ruthenium Complex-Loaded Cross-linked Polymeric Nanoassemblies for the Treatment of Cancer |
| Q37824297 | Mass spectrometry as test bench for medicinal chemistry studies |
| Q37354918 | Mechanism of cellular uptake of a ruthenium polypyridyl complex |
| Q37996311 | Mercury-based traditional herbo-metallic preparations: a toxicological perspective. |
| Q64083772 | Metal-Ligand Recognition Index Determination by NMR Proton Relaxation Study |
| Q37382191 | Metals in anticancer therapy: copper(II) complexes as inhibitors of the 20S proteasome |
| Q42560798 | Methods to explore cellular uptake of ruthenium complexes |
| Q35625019 | Mixed ligand copper(II) dicarboxylate complexes: the role of co-ligand hydrophobicity in DNA binding, double-strand DNA cleavage, protein binding and cytotoxicity |
| Q36514784 | Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations |
| Q37767597 | Molecular modeling and dynamics studies with explicit inclusion of electronic polarizability. Theory and applications |
| Q50063144 | Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates |
| Q37703236 | Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene. |
| Q38777400 | New Look on 3-Hydroxyiminoflavanone and Its Palladium(II) Complex: Crystallographic and Spectroscopic Studies, Theoretical Calculations and Cytotoxic Activity. |
| Q37027906 | New dicoumarol sodium compound: crystal structure, theoretical study and tumoricidal activity against osteoblast cancer cells |
| Q35029887 | New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity |
| Q39153295 | Novel tetranuclear triarylantimony(V) complexes with (±)-mandelic acid ligands: synthesis, characterization, in vitro cytotoxicity and DNA binding properties |
| Q39369795 | Organogold(III) supramolecular polymers for anticancer treatment |
| Q42555974 | Organometallic cis-Dichlorido Ruthenium(II) Ammine Complexes |
| Q37277525 | Photoinduced electron transfer from PbS quantum dots to cobalt(III) Schiff base complexes: light activation of a protein inhibitor |
| Q45064469 | Platinum (IV) pro-drug conjugated NaYF4 :Yb(3+) /Er(3+) nanoparticles for targeted drug delivery and up-conversion cell imaging. |
| Q40537950 | Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties |
| Q36253687 | Polymeric Micelle-Mediated Delivery of DNA-Targeting Organometallic Complexes for Resistant Ovarian Cancer Treatment |
| Q37211504 | Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery |
| Q34331245 | Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands |
| Q46716587 | Potent in vitro anti-Trypanosoma cruzi activity of pyridine-2-thiol N-oxide metal complexes having an inhibitory effect on parasite-specific fumarate reductase. |
| Q39327176 | Potential cytotoxic and amoebicide activity of first row transition metal compounds with 2,9-bis-(2',5'-diazahexanyl)-1,1-phenanthroline (L1). |
| Q38551590 | Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies. |
| Q40064331 | Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs |
| Q126334895 | RETRACTED ARTICLE: Synthesis of a crystalline nanoscale Co(II)-coordination polymer based on the 4,4′-bis(imidazol-1-yl)-biphenyl ligand: structural characterization and liver cancer cell growth inhibition |
| Q38316048 | RNA binding and inhibition of primer extension by a Ru(III)/Pt(II) metal complex |
| Q38569329 | Recent trends in the development of vitamin B12 derivatives for medicinal applications |
| Q28647465 | Revealing Three Stages of DNA-Cisplatin Reaction by a Solid-State Nanopore |
| Q47970194 | Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation. |
| Q41924405 | Ruthenation of Non-stacked Guanines in DNA G-Quadruplex Structures: Enhancement of c-MYC Expression. |
| Q39280971 | Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation |
| Q35183003 | Ruthenium polypyridyl complex inhibits growth and metastasis of breast cancer cells by suppressing FAK signaling with enhancement of TRAIL-induced apoptosis |
| Q37982323 | Ruthenium(II) polypyridyl complexes and DNA--from structural probes to cellular imaging and therapeutics. |
| Q39121561 | Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies. |
| Q46106014 | Salen-Mn compounds induces cell apoptosis in human prostate cancer cells through promoting AMPK activity and cell autophagy |
| Q42692990 | Specific blocking of CREB/DNA binding by cyclometalated platinum(II) complexes |
| Q53573988 | Steroid conjugates of dichloro(6-aminomethylnicotinate)platinum(II): effects on DNA, sex hormone binding globulin, the estrogen receptor, and various breast cancer cell lines. |
| Q27015050 | Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market |
| Q34002901 | Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor. |
| Q39495236 | Studies on the cytotoxic, apoptotic and antitumoral effects of Au(III) and Pt(II) complexes of 1, 10-phenanthroline on V79 379A and A549 cell lines |
| Q57059874 | Superoxide dismutase activity enabled by a redox-active ligand rather than metal |
| Q42281852 | Synthesis Characterization and Biological Activities of Coordination Compounds of 4-Hydroxy-3-nitro-2H-chromen-2-one and Its Aminoethanoic Acid and Pyrrolidine-2-carboxylic Acid Mixed Ligand Complexes |
| Q58766793 | Synthesis and Characterization of -Dichlorotetrakis(imidazole)cobalt(III) Chloride: A New Cobalt(III) Coordination Complex with Potential Prodrug Properties |
| Q53238954 | Synthesis and enantiopreferential DNA-binding profile of late 3d transition metal R- and S-enantiomeric complexes derived from N,N-bis-(1-benzyl-2-ethoxyethane): Validation of R-enantiomer of copper(II) complex as a human topoisomerase II inhibitor. |
| Q39660171 | Synthesis of carbohydrate-conjugate heterobimetallic CuII–Sn2IV and ZnII–Sn2IV complexes; their interactions with CT DNA and nucleotides; DNA cleavage, in-vitro cytotoxicity |
| Q41200507 | Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action |
| Q46378820 | Synthesis, Spectral Properties and DFT Calculations of new Ruthenium (II) Polypyridyl Complexes; DNA Binding Affinity and in Vitro Cytotoxicity Activity. |
| Q36465031 | Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor Agents |
| Q38881471 | Synthesis, characterization, DNA/BSA interactions and anticancer activity of achiral and chiral copper complexes |
| Q46943866 | Synthesis, characterization, and binding properties towards CT-DNA and lipoxygenase of mixed-ligand silver(I) complexes with 2-mercaptothiazole and its derivatives and triphenylphosphine |
| Q36270717 | Synthesis, characterization, and evaluation of cis-diphenyl pyridineamine platinum(II) complexes as potential anti-breast cancer agents |
| Q37169192 | Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine |
| Q39465410 | Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine |
| Q41247063 | Synthesis, characterization, in vitro antimicrobial, and U2OS tumoricidal activities of different coumarin derivatives. |
| Q36854716 | Synthesis, structures, and electrochemistry of gold(III) ethylenediamine complexes and interactions with guanosine 5'-monophosphate |
| Q39775092 | Tautomeric forms study of 1H-(2'-pyridyl)-3-methyl-5-hydroxypyrazole and 1H-(2'-pyridyl)-3-phenyl-5-hydroxypyrazole. Synthesis, structure, and cytotoxic activity of their complexes with palladium(II) ions |
| Q39400527 | The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials |
| Q38880669 | The gold (III) porphyrin complex, gold-2a, suppresses WNT1 expression in breast cancer cells by enhancing the promoter association of YY1. |
| Q51040701 | The influence of oxo-bridged binuclear gold(III) complexes on Na/K-ATPase activity: a joint experimental and theoretical approach. |
| Q26999667 | The path for metal complexes to a DNA target |
| Q39111089 | The relationship between electrospray ionization behavior and cytotoxic activity of [M(I)(P)4](+)-type complexes (M = Cu, Ag and Au; P = tertiary phosphine). |
| Q40003392 | Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents. |
| Q40089378 | Trans-platinum(II) complexes with cyclohexylamine as expectator ligand induce necrosis in tumour cells by inhibiting DNA synthesis and RNA transcription. |
| Q40484991 | Transfer of Copper from an Amyloid to a Natural Copper-Carrier Peptide with a Specific Mediating Ligand. |
| Q33640724 | Transferring the concept of multinuclearity to ruthenium complexes for improvement of anticancer activity |
| Q37670137 | Triggering autophagic cell death with a di-manganese(II) developmental therapeutic |
| Q35040088 | Tumor-targeting novel manganese complex induces ROS-mediated apoptotic and autophagic cancer cell death |
| Q37855894 | Tuning heavy metal compounds for anti-tumor activity: is diversity the key to ruthenium's success? |
| Q46679681 | Unexpected DNA binding properties with correlated downstream biological applications in mono vs. bis-1,8-naphthalimide Ru(II)-polypyridyl conjugates. |
| Q37226453 | Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells |
| Q39184979 | Zinc(II) complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers that trigger DNA damage-mediated p53 phosphorylation in cancer cells. |
| Q92681136 | trans-Platinum(II) Thionate Complexes: Synthesis, Structural Characterization, and in vitro Biological Assessment as Potent Anticancer Agents |
Search more.